---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-066746"
form_type: "8-K"
ticker: null
cik: "0001850838"
company_name: "Omega Therapeutics, Inc."
filed_at: "2024-05-30T23:59:59+00:00"
generated_at: "2026-06-01T07:28:28.044229+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Omega Therapeutics CMO Yan Moore departs; appoints Kaan Certel as Chief Business Officer

## Summary
- CMO Yan Moore's employment terminated effective May 31, 2024; separation agreement with severance per employment agreement.
- Company expects seamless continuation of Phase 1/2 trial for OTX-2002 (hepatocellular carcinoma); search for successor underway.
- Appointed Kaan Certel, Ph.D. as Chief Business Officer effective May 28, 2024; over 20 years of biopharma experience.
- Dr. Certel to lead global business development and strategic partnerships.

## SEC filing metadata
- accession: 0000950170-24-066746
- form_type: 8-K
- cik: 0001850838
- company_name: Omega Therapeutics, Inc.
- filed_at: 2024-05-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850838/000095017024066746/0000950170-24-066746-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850838/000095017024066746/omga-20240528.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-066746
- JSON: https://secwatch.observer/filing/0000950170-24-066746.json
- Plain text: https://secwatch.observer/filing/0000950170-24-066746.txt

## Key facts
- Executive change
  Yan Moore departed as Chief Medical Officer at Omega Therapeutics, Inc..
  - Action: agreed to terminate his employment
  - Role: Chief Medical Officer
  source text: On May 28, 2024, Omega Therapeutics, Inc. (the “Company”) and Yan Moore, M.D., the Company’s Chief Medical Officer, agreed to terminate his employment effective as of May 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850838/000095017024066746/0000950170-24-066746-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.